These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14725638)

  • 1. Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism: II. Effects of reward preference.
    Pessiglione M; Guehl D; Jan C; François C; Hirsch EC; Féger J; Tremblay L
    Eur J Neurosci; 2004 Jan; 19(2):437-46. PubMed ID: 14725638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism. I. Effects of task complexity.
    Pessiglione M; Guehl D; Hirsch EC; Féger J; Tremblay L
    Eur J Neurosci; 2004 Jan; 19(2):426-36. PubMed ID: 14725637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.
    Mounayar S; Boulet S; Tandé D; Jan C; Pessiglione M; Hirsch EC; Féger J; Savasta M; François C; Tremblay L
    Brain; 2007 Nov; 130(Pt 11):2898-914. PubMed ID: 17855373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys.
    Jan C; Pessiglione M; Tremblay L; Tandé D; Hirsch EC; François C
    Eur J Neurosci; 2003 Oct; 18(7):2082-6. PubMed ID: 14622241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus).
    Taylor JR; Elsworth JD; Roth RH; Sladek JR; Redmond DE
    Neuroscience; 1997 Dec; 81(3):745-55. PubMed ID: 9316026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier.
    Taylor JR; Roth RH; Sladek JR; Redmond DE
    Behav Neurosci; 1990 Aug; 104(4):564-76. PubMed ID: 2206426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson's disease.
    Pessiglione M; Guehl D; Agid Y; Hirsch EC; Féger J; Tremblay L
    Brain; 2003 Jun; 126(Pt 6):1392-408. PubMed ID: 12764060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nicotinic therapies on attention and executive functions in chronic low-dose MPTP-treated monkeys.
    Decamp E; Schneider JS
    Eur J Neurosci; 2006 Oct; 24(7):2098-104. PubMed ID: 17067307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits.
    Pessiglione M; Guehl D; Rolland AS; François C; Hirsch EC; Féger J; Tremblay L
    J Neurosci; 2005 Feb; 25(6):1523-31. PubMed ID: 15703406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S
    Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease.
    Goldstein DS; Li ST; Holmes C; Bankiewicz K
    J Pharmacol Exp Ther; 2003 Sep; 306(3):855-60. PubMed ID: 12805479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
    Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH
    Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys.
    Taylor JR; Elsworth JD; Roth RH; Sladek JR; Redmond DE
    Brain; 1990 Jun; 113 ( Pt 3)():617-37. PubMed ID: 2364263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
    Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
    J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
    Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
    Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias.
    Kordower JH; Vinuela A; Chu Y; Isacson O; Redmond DE
    J Comp Neurol; 2017 Feb; 525(3):498-512. PubMed ID: 27418401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic aspartame consumption on MPTP-induced Parkinsonism in male and female mice.
    Amin SN; Hassan SS; Rashed LA
    Arch Physiol Biochem; 2018 Oct; 124(4):292-299. PubMed ID: 29096532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Masilamoni GJ; Groover O; Smith Y
    Neurobiol Dis; 2017 Apr; 100():9-18. PubMed ID: 28042095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson׳s disease-related modulation of functional connectivity associated with the striatum in the resting state in a nonhuman primate model.
    Li J; Luo C; Chen Y; Chen Q; Huang R; Sun J; Gong Q; Wu X; Qi Z; Liang Z; Li L; Li H; Li P; Wang W; Shang HF
    Brain Res; 2014 Mar; 1555():10-9. PubMed ID: 24530271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
    German DC; Manaye KF; Sonsalla PK; Brooks BA
    Ann N Y Acad Sci; 1992 May; 648():42-62. PubMed ID: 1353337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.